Business registries · firm from USPTO records

CymaBay Therapeutics, Inc.

Place
7575 Gateway Boulevard, Suite 110, Newark, CA
Entity type
Corporation
State of organization
DE (as the owner states it in trademark filings)
Patents
42 granted 2013-06-07 to 2023-10-03
Trademarks
19, 11 live
Record
EXACT high confidence: identical full name and state
Form D issuer
CymaBay Therapeutics, Inc. EXACT high confidence: identical full name and state
Source
USPTO: PVGPATDIS and TRCFECO2 (PVGPATDIS file of 2026-04-10, TRCFECO2 file of 2024-03-27); patent assignee and trademark owner with the same name (legal endings aside) and place

Patents

PatentTitleGrantedSource
US 11596614Treatment of intrahepatic cholestatic diseases2023-03-07PVGPATDIS, file of 2026-04-10
US 11406611Treatment of intrahepatic cholestatic diseases2022-08-09PVGPATDIS, file of 2026-04-10
US 11224580Treatment of intrahepatic cholestatic diseases2022-01-18PVGPATDIS, file of 2026-04-10
US 11179359Treatment of NAFLD and NASH2021-11-23PVGPATDIS, file of 2026-04-10
US 11007162Methods of reducing small, dense LDL particles2021-05-18PVGPATDIS, file of 2026-04-10
US 11000494Treatment of intrahepatic cholestatic diseases2021-05-11PVGPATDIS, file of 2026-04-10
US 10828273Treatment of intrahepatic cholestatic diseases2020-11-10PVGPATDIS, file of 2026-04-10
US 10813896Treatment of intrahepatic cholestatic diseases2020-10-27PVGPATDIS, file of 2026-04-10
US 10813895Treatment of intrahepatic cholestatic diseases2020-10-27PVGPATDIS, file of 2026-04-10
US 10722483Treatment of NAFLD and NASH2020-07-28PVGPATDIS, file of 2026-04-10
US 10512622Treatment of intrahepatic cholestatic diseases2019-12-24PVGPATDIS, file of 2026-04-10
US 10478411Treatment of intrahepatic cholestatic diseases2019-11-19PVGPATDIS, file of 2026-04-10
US 10342770Treatment of NAFLD and NASH2019-07-09PVGPATDIS, file of 2026-04-10
US 10292983Oxymethylene aryl compounds for treating inflammatory gastrointestinal diseases or gastrointestinal conditions2019-05-21PVGPATDIS, file of 2026-04-10
US 10272058Treatment of intrahepatic cholestatic diseases2019-04-30PVGPATDIS, file of 2026-04-10
US 10220011Treatment of intrahepatic cholestatic diseases2019-03-05PVGPATDIS, file of 2026-04-10
US 10188620Treatment for NAFLD and NASH2019-01-29PVGPATDIS, file of 2026-04-10
US 10137112Methods for treating hyperuricemia in patients with gout using halofenate or halofenic acid and a second urate-lowering agent2018-11-27PVGPATDIS, file of 2026-04-10
US 10098843Compositions of 5-ethyl-2-{4-[4-(4-tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl]-piperidin-1-yl}-pyrimidine2018-10-16PVGPATDIS, file of 2026-04-10
US 9962346Treatment of NAFLD and NASH2018-05-08PVGPATDIS, file of 2026-04-10
US 9925189Heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders2018-03-27PVGPATDIS, file of 2026-04-10
US 9845285Crystalline solid and amorphous forms of (−)-halofenate and methods related thereto2017-12-19PVGPATDIS, file of 2026-04-10
US 9808436Treatment of intrahepatic cholestatic diseases2017-11-07PVGPATDIS, file of 2026-04-10
US 9801860Methods for treating hyperuricemia in patients with gout using halofenate or halofenic acid and a second urate-lowering agent2017-10-31PVGPATDIS, file of 2026-04-10
US 9737537Heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders2017-08-22PVGPATDIS, file of 2026-04-10

The newest 25 of 42. All patents of this assignee

Trademarks

MarkSerialFiledStatusClassesSource
(design)990852462025-03-14Registered005TRTYRAP, file of 2026-04-03
LIVDELZI985170682024-04-24Registered005TRTDXFAP, file of 2026-05-13
LIVDELZI984959812024-04-11Registered005TRTDXFAP, file of 2026-02-26
CYMABAY THERAPEUTICS982084662023-10-03Abandoned005TRTYRAP, file of 2026-04-03
LIVDELZI981465142023-08-23Registered005TRTYRAP, file of 2026-04-03
LIVDELZI981465102023-08-23Registered005TRTYRAP, file of 2026-04-03
LYVDELZI977694542023-01-26Abandoned005TRTYRAP, file of 2026-04-03
EPDELZIQ975973632022-09-19Abandoned005TRTDXFAP, file of 2026-01-14
DELVYFY975973552022-09-19Abandoned005TRTDXFAP, file of 2026-01-14
BETTER TO SWITCH THAN ITCH975294202022-08-01Abandoned005, 042TRTYRAP, file of 2026-04-03
DELMINPRI974151202022-05-17Abandoned005TRCFECO2, file of 2024-03-27
QDELZIQ974151112022-05-17Abandoned005TRTDXFAP, file of 2026-01-14
LYVDELZI888672492020-04-10Abandoned005TRCFECO2, file of 2024-03-27
GODEYO888672242020-04-10Abandoned005TRCFECO2, file of 2024-03-27
LIVDELZI886540392019-10-14Registered005TRTYRAP, file of 2026-04-03
DELSELZO886540282019-10-14Abandoned005TRCFECO2, file of 2024-03-27
GOVEYO886540192019-10-14Abandoned005TRCFECO2, file of 2024-03-27
CYMABAY THERAPEUTICS889803072019-10-09Registered042TRTDXFAP, file of 2026-03-04
CYMABAY THERAPEUTICS886485322019-10-09Abandoned005TRCFECO2, file of 2024-03-27
BETTER TO SWITCH THAN ITCH883451682019-03-18Abandoned005, 042TRCFECO2, file of 2024-03-27
CYMABAY859542992013-06-07Abandoned005TRCFECO2, file of 2024-03-27
CYMABAY859542912013-06-07Registration cancelled042TRTDXFAP, file of 2026-10-03

All marks of this owner

No other firm on file at the same street address.

Firms here are built from USPTO patent assignees (PatentsView) and trademark owners: one firm per name (legal endings aside) and state, or country outside the US. Matches to other records are by name and state: EXACT means the identical full name, FUZZY a looser match, with the confidence shown.